{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:25:08Z","timestamp":1793798708927,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2024A03J0242"],"award-info":[{"award-number":["2024A03J0242"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023A04J1948"],"award-info":[{"award-number":["2023A04J1948"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2025A03J3187"],"award-info":[{"award-number":["2025A03J3187"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515012293"],"award-info":[{"award-number":["2025A1515012293"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cca.2026.121026","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:36:28Z","timestamp":1777131388000},"page":"121026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["High-throughput UHPLC\u2013MS\/MS method for 15 protein-bound uremic toxins in human serum"],"prefix":"10.1016","volume":"589","author":[{"given":"Qiong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cca.2026.121026_bb0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.kint.2024.11.013","article-title":"Chronic kidney disease\u2013mineral and bone disorder: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"107","author":"Ketteler","year":"2025","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.cca.2026.121026_bb0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ndt\/gfad185","article-title":"Recommended calcium intake in adults and children with chronic kidney disease\u2014a European consensus statement","volume":"39","author":"Evenepoel","year":"2024","journal-title":"Nephrol. Dialysis Transp."},{"issue":"20","key":"10.1016\/j.cca.2026.121026_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012223","article-title":"Mineral bone disorders in kidney disease patients: the ever-current topic","volume":"23","author":"Hu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cca.2026.121026_bb0020","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3390\/nu15061470","article-title":"Serum and urinary soluble \u03b1-klotho as markers of kidney and vascular impairment","volume":"15","author":"Mart\u00edn-V\u00edrgala","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.cca.2026.121026_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41413-023-00291-8","article-title":"Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort","volume":"11","author":"Reimer","year":"2023","journal-title":"Bone Res."},{"issue":"3","key":"10.1016\/j.cca.2026.121026_bb0030","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3390\/ijms25031843","article-title":"Soluble klotho, a potential biomarker of chronic kidney disease-mineral bone disorders involved in healthy ageing: lights and shadows","volume":"25","author":"Mart\u00edn-V\u00edrgala","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cca.2026.121026_bb0035","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1681\/ASN.2021101327","article-title":"Interventions to attenuate vascular calcification progression in chronic kidney disease: a systematic review of clinical trials","volume":"33","author":"Xu","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.cca.2026.121026_bb0040","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.kint.2020.07.002","article-title":"Mineral and bone disorder in chronic kidney disease: pioneering studies","volume":"98","author":"Floege","year":"2020","journal-title":"Kidney Int."},{"issue":"Supplement_1","key":"10.1016\/j.cca.2026.121026_bb0045","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/ckj\/sfae431","article-title":"Pathophysiology of chronic kidney disease\u2013mineral bone disorder (CKD-MBD): from adaptive to maladaptive mineral homeostasis","volume":"18","author":"Salera","year":"2025","journal-title":"Clin. Kidney J."},{"issue":"5","key":"10.1016\/j.cca.2026.121026_bb0050","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.ajkd.2021.07.027","article-title":"Diagnostic accuracy of noninvasive bone turnover markers in renal osteodystrophy","volume":"79","author":"J\u00f8rgensen","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2026.121026_bb0055","article-title":"Static histomorphometry allows for a diagnosis of bone turnover in renal osteodystrophy in the absence of tetracycline labels","volume":"152","year":"2021","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.cca.2026.121026_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfad290","article-title":"Real-world usage of chronic kidney disease \u2013 mineral bone disorder (CKD\u2013MBD) biomarkers in nephrology practices","volume":"17","author":"Fusaro","year":"2024","journal-title":"Clin. Kidney J."},{"issue":"5","key":"10.1016\/j.cca.2026.121026_bb0065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1053\/j.ajkd.2023.04.003","article-title":"Vitamin d therapy in adults with CKD: a systematic review and meta-analysis","volume":"82","author":"Yeung","year":"2023","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.cca.2026.121026_bb0070","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/toxins13040274","article-title":"Contribution of gut microbiota-derived uremic toxins to the cardiovascular system mineralization","volume":"13","author":"Filipska","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"9","key":"10.1016\/j.cca.2026.121026_bb0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/toxins10090352","article-title":"Cardiotoxicity of uremic toxins: a driver of cardiorenal syndrome","volume":"10","author":"Lekawanvijit","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.cca.2026.121026_bb0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.jrn.2011.10.031","article-title":"Role of uremic toxins and oxidative stress in the development of chronic kidney disease-mineral and bone disorder","volume":"22","author":"Tanaka","year":"2012","journal-title":"J. Ren. Nutr."},{"issue":"12","key":"10.1016\/j.cca.2026.121026_bb0085","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.2215\/CJN.02660221","article-title":"Classification of uremic toxins and their role in kidney failure","volume":"16","author":"Rosner","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.cca.2026.121026_bb0090","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.3390\/cells9112428","article-title":"Uremic toxins affecting cardiovascular calcification: a systematic review","volume":"9","author":"Holmar","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.cca.2026.121026_bb0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/toxins13020142","article-title":"Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets","volume":"13","author":"Lim","year":"2021","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.cca.2026.121026_bb0100","article-title":"Uremic toxins in organ crosstalk","volume":"8","author":"Lowenstein","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"issue":"15","key":"10.1016\/j.cca.2026.121026_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512435","article-title":"Bioengineered kidney tubules efficiently clear uremic toxins in experimental dialysis conditions","volume":"24","author":"Faria","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cca.2026.121026_bb0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/toxins13020116","article-title":"PH-dependent protein binding properties of uremic toxins in vitro","volume":"13","author":"Yamamoto","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.cca.2026.121026_bb0115","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/advances\/nmab149","article-title":"Effects of microbiota-driven therapy on circulating indoxyl sulfate and P-Cresyl sulfate in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Chen","year":"2022","journal-title":"Adv. Nutr."},{"issue":"6","key":"10.1016\/j.cca.2026.121026_bb0120","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/ndt\/gfab004","article-title":"Free P-Cresyl sulfate shows the highest association with cardiovascular outcome in chronic kidney disease","volume":"36","author":"Glorieux","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"issue":"9","key":"10.1016\/j.cca.2026.121026_bb0125","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3390\/nu14091687","article-title":"Does mediterranean adequacy index correlate with cardiovascular events in patients with advanced chronic kidney disease? An exploratory study","volume":"14","author":"De Mauri","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.cca.2026.121026_bb0130","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1080\/0886022X.2022.2136528","article-title":"P-Cresyl sulfate predicts clinical outcomes in sustained peritoneal dialysis: a 5-year follow-up cohort study and Meta-analysis","volume":"44","author":"Chen","year":"2022","journal-title":"Ren. Fail."},{"issue":"2","key":"10.1016\/j.cca.2026.121026_bb0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semnephrol.2014.02.004","article-title":"Protein-bound molecules: a large family with a bad character","volume":"34","author":"Sirich","year":"2014","journal-title":"Semin. Nephrol."},{"issue":"19","key":"10.1016\/j.cca.2026.121026_bb0140","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0024-3205(01)01309-1","article-title":"Kinetics of the protein-bound, lipophilic, uremic toxin p-cresol in healthy rats","volume":"69","author":"Lesaffer","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.cca.2026.121026_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123578","article-title":"Sample preparation and chromatographic methods for the determination of protein-bound uremic retention solutes in human biological samples: an overview","volume":"1215","author":"Fernandes","year":"2023","journal-title":"J. Chromatogr. B"},{"issue":"4","key":"10.1016\/j.cca.2026.121026_bb0150","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00216-022-04458-w","article-title":"Rapid and sustainable HPLC method for the determination of uremic toxins in human plasma samples","volume":"415","author":"Silva","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"issue":"12","key":"10.1016\/j.cca.2026.121026_bb0155","article-title":"Improvised method for urinary P-cresol detection and measurement using high performance liquid chromatography\/mass spectrometry","volume":"5","year":"2019","journal-title":"Heliyon"},{"issue":"29","key":"10.1016\/j.cca.2026.121026_bb0160","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1016\/j.jchromb.2010.09.006","article-title":"Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography\/tandem mass spectrometry","volume":"878","author":"Kikuchi","year":"2010","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cca.2026.121026_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124445","article-title":"Liquid chromatography coupled with high resolution mass spectrometry reveals the inhibitory effects of Huangkuisiwu formula on biosynthesis of protein-binding uremic toxins in rats with chronic kidney disease","volume":"1252","author":"Li","year":"2025","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"4","key":"10.1016\/j.cca.2026.121026_bb0170","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1039\/C6RA24152B","article-title":"A metabolomics approach for predicting the response to intravenous iron therapy in peritoneal dialysis patients with anemia","volume":"7","author":"Wu","year":"2017","journal-title":"RSC Adv."},{"issue":"32","key":"10.1016\/j.cca.2026.121026_bb0175","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001273","article-title":"Evidence for chronic kidney disease-mineral and bone disorder associated with metabolic pathway changes","volume":"94","author":"Wu","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2026.121026_bb0180","first-page":"1","article-title":"UPLC-QTOF MS-based serum metabolomic profiling analysis reveals the molecular perturbations underlying uremic pruritus","volume":"2018","author":"Wu","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.cca.2026.121026_bb0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1208\/s12248-019-0397-8","article-title":"Current perspectives on ligand-binding assay practices in the quantification of circulating therapeutic proteins for biosimilar biological product development","volume":"22","author":"Thway","year":"2019","journal-title":"AAPS J."},{"issue":"7","key":"10.1016\/j.cca.2026.121026_bb0190","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.ekir.2025.04.040","article-title":"Furosemide and serum protein-bound uremic toxin concentrations in patients with CKD","volume":"10","author":"Costes-Albrespic","year":"2025","journal-title":"Kidney Int. Rep."},{"issue":"3","key":"10.1016\/j.cca.2026.121026_bb0195","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.kint.2025.06.004","article-title":"Medium chain fatty acids are potent binding competitors to improve protein-bound uremic toxin clearance during hemodialysis","volume":"108","author":"Raillon","year":"2025","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.cca.2026.121026_bb0200","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1021\/acs.jmedchem.5c00418","article-title":"3,5-Dihydroxybenzoic acid as a potent inhibitor of tyrosine phenol-Lyase decreases fecal phenol levels in mice","volume":"68","author":"Kobayashi","year":"2025","journal-title":"J. Med. Chem."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T22:13:34Z","timestamp":1783203214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126002081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":40,"alternative-id":["S0009898126002081"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121026","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-throughput UHPLC\u2013MS\/MS method for 15 protein-bound uremic toxins in human serum","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121026"}}